RxDoctor Payments DataLook up a doctor →

Hyun Bang, MD

Vascular & Interventional Radiology · Brandywine, MDNPI 1336452036

Payments from drug & device makers

$31,346in general payments, 2019–2025

Across 423 payments — averaging $74.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$9K
  • Biocompatibles, Inc.$8K
  • Abbott$6K
  • Philips North America LLC$2K
  • Boston Scientific$2K
  • Cardiovascular Systems Inc.$2K
  • plus $1K from 15 others

What the payments were for

  • Consulting fees$6,90022%
  • Speaking & faculty fees$2,2007%
  • Travel & lodging$1,0933%
  • Food & beverage$19,90463%
  • Education$1,2504%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,346 in reported general payments places this provider in the 85th percentile of 75 vascular & interventional radiology providers in Maryland.

See all vascular & interventional radiology providers in Maryland

Medicare billing

Part B allowed, 2024
$1,601,655
Medicare patients
1,191
Services billed
5,225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate125$1,455

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Brandywine

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →